111 Inc 1 ADR represents 2 Class Common stocks YI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
111, Inc. Announces Establishment of the Special Committee
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
Trading Information
- Previous Close Price
- $2.84
- Day Range
- $2.73–2.85
- 52-Week Range
- $0.00–11.17
- Bid/Ask
- $2.71 / $3.00
- Shares Outstanding
- 8.80M
- Market Cap
- $24.35M
- Volume/Avg
- 1,326 / 15,476
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.02
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- —
- Total Number of Employees
- 1,063
- Website
- https://ir.111.com.cn
Valuation
Metric | YI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.02 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | YI |
|---|---|
Quick Ratio | 0.38 |
Current Ratio | 1.07 |
Interest Coverage | −0.97 |
Quick Ratio
YI
Profitability
Metric | YI |
|---|---|
Return on Assets (Normalized) | −6.39% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −21.46% |
Return on Assets
YI
Medical Distribution Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| McKesson Corp MCK | LOCK|MnWmC% | LOCK|%>l@ | $126B | |||
| Cencora Inc COR | LOCK|BJM$^^^ | LOCK|%QK#P | $67B | |||
| Cardinal Health Inc CAH | LOCK|@$D?%t | LOCK|#@$p% | $65B | |||
| Sigma Healthcare Ltd SIGGF | — | LOCK|kq>g | $23B | |||
| Henry Schein Inc HSIC | LOCK|&T@#Brt | LOCK|$g%h | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY | — | LOCK|S& | $8B | |||
| Sinopharm Group Co Ltd ADR SHTDY | — | LOCK|gc | $7B | |||
| Sinopharm Group Co Ltd SHTDF | — | LOCK|>B | $7B | |||
| Galenica Ltd GALNF | — | LOCK|FT@ | $5B | |||
| Medipal Holdings Corp MEPDF | — | LOCK|G$ | $4B |